March 19 (Reuters) - CSL Ltd (CSL) :
- FERINJECT® APPROVED BY HEALTH CANADA FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN ADULT AND PEDIATRIC PATIENTS AND IRON DEFICIENCY IN ADULT PATIENTS WITH HEART FAILURE
- CSL LTD: IN CANADA, FERINJECT IS COMMERCIALIZED THROUGH CSL BEHRING CANADA, INC., WITH AVAILABILITY EXPECTED IN SECOND HALF OF 2024
News: CSL Ferinject Approved By Health Canada For The Treatment Of Iron Deficiency Anemia In Adult...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$279.74 |
Change
-0.180(0.06%) |
Mkt cap ! $135.3B | |||
| Open | High | Low | Value | Volume |
| $279.97 | $282.07 | $279.66 | $66.09M | 235.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 131 | $279.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $279.77 | 29 | 3 |
View Market Depth
| Last trade - 14.29pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$279.93 |
Change
-0.180 ( 0.02 %) |
||||
| Open | High | Low | Volume | ||
| $280.00 | $282.05 | $279.55 | 25357 | ||
| Last updated 14.48pm 14/05/2024 ? | |||||
| CSL (ASX) Chart |